APRE
Aprea Therapeutics, Inc.
Recent 8-K filings for APRE
Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.
-
May 13, 2026 10:35 UTC earnings item 2.02item 8.01item 9.01
Aprea Q1 net loss $3.3M ($0.22/sh); cash $46.5M; APR-1051 shows two partial responses
source · APRE on sec.gov